CorMedix (CRMD) announced it will be added to the Nasdaq Biotechnology Index (NBI). CorMedix’s addition to the NBI will become effective prior to the market open on Monday, December 23, 2024.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRMD: